Cardiovascular Morbidity Recruiting Phase Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0042402 (Cardiovascular Morbidity)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03199300Investigating Cardiovascular Adverse Events Related to Cancer Treatment